Please join our masterclass panel of experts to discuss process intensification in AAV Gene Therapy. Demand for AAV vectors is rising with more than 550 adeno associated viral vector therapies being developed for the treatment of various disorders. As numerous biotech companies are planning to introduce these transformative gene therapies, they find themselves struggling to